BEIJING (dpa-AFX) - China Pharma Holdings (CPHI) announced that through Hainan Helpson Medical and Biotechnology Co., a wholly owned subsidiary, it expects to launch Dry Eye Disease Therapeutic Device in the first quarter of 2025 in China. It is a medical treatment device for dry eye disease under patent protection. The company, through Helpson, acquired the technology at the end of 2022.
China Pharma Holdings is a specialty pharmaceutical company that develops, manufactures, and markets a diversified portfolio of products, focusing on conditions with high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases.
For More Such Health News, visit rttnews.com.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2024 AFX News
